Abstract
Objective
Lactic acid bacteria (LAB) can improve disturbances of indigenous microflora as well as inflammatory bowel diseases (IBD) such as ulcerative colitis and Crohn’s disease. We examined the anticolitic effect of Lactobacillus suntoryeus HY7801, which inhibited toll-like receptor (TLR)-4-linked NF-κB activation in human embryonic kidney (HEK) cells, in 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced colitic mice.
Materials and methods
We measured the ability of commercial and intestinal LAB to inhibit lipopolysaccharide (LPS)-stimulated, TLR-4-linked NF-κB activation in HEK cells, as well as to inhibit colitis outcomes in TNBS-induced colitic mice. We also measured levels of the inflammatory markers, interleukin (IL)-1β, tumor necrosis factor (TNF)-α, and IL-6, and their transcription factor, NF-κB, in intestinal mucosa by enzyme-linked immunosorbent assay and immunoblotting.
Results and discussion
LAB inhibited TLR-4-linked NF-κB activation, and L. suntoryeus HY7801 was the most potent inhibitor. Intrarectal treatment of TNBS in mice caused colon shortening and also increased colonic expression of IL-1β, IL-6, and TNF-α expression. However, oral administration of Lactobacillus HY7801 (100 mg/kg) inhibited colon shortening (p < 0.001) and myeloperoxidase activity in TNBS-induced colitic mice (p < 0.0002) and also decreased colonic expression of \(IL - 1\mathop \beta \limits_ \cdot \) (p < 0.003), IL-6 (p < 0.0001), and TNF-α (p < 0.0001). Lactobacillus HY7801 inhibited the NF-κB activation and TLR-4 expression induced by TNBS, as well as the expression of cyclooxygenase 2. Lactobacillus HY7801 also reduced the activity of intestinal bacterial glycosaminoglycan degradation and β-glucuronidase induced by TNBS.
Conclusion
L. suntoryeus HY7801 can improve colitis via the inhibition of TLR-4-linked NF-κB activation.
Similar content being viewed by others
Abbreviations
- IBD:
-
inflammatory bowel disease
- DMEM:
-
Dulbecco’s modified Eagle’s medium
- ECL:
-
enhanced chemiluminescence
- ELISA:
-
enzyme-linked immunosorbent assay
- HEK:
-
human embryonic kidney
- IL:
-
interleukin
- LAB:
-
lactic acid bacteria
- LPS:
-
lipopolysaccharide
- RIPA:
-
radio-immunoprecipitation assay
- TLR:
-
toll-like receptor
- TNBS:
-
2,4,6-trinitrobenzenesulfonic acid
- TNF:
-
tumor necrosis factor
References
Benno P, Leijonmarck CE, Monsen U, Uribe A (1993) Functional alteration of the microflora in patients with ulcerative colitis. Scand J Gastroenterol 28:839–844
Berrebi D, Languepin J, Ferkdadji L, Foussat A, De Lagausie P, Paris R, Emilie D, Mougenot JF, Cezard JP, Navarro J, Peuchmaur M (2003) Cytokines, chemokine receptors, and homing molecule distribution in the rectum and stomach of pediatric patients with ulcerative colitis. J Pediatr Gastroenterol Nutr 37:300–308
Gorbach SL, Nahas L (1968) Studies of intestinal microflora. V. Fecal microbial ecology in ulcerative colitis and regional enteritis, relationship to severity of disease and chemotherapy. Gastroenterology 54:575–587
Binder V (2004) Epidemiology of IBD during the twentieth century: an integrated view. Best Pract Res Clin Gastroenterol 18:463–479
Chandran P, Satthaporn Robins A, Eremin O (2003) Inflammatory bowel disease: dysfunction of GALT and gut bacterial flora (II). Surgeon 1:125–136
Hill MJ, Drasar BS (1975) The normal colonic bacterial flora. Gut 16:318–323
Simon GL, Gorbach SL (1984) Intestinal flora in health and disease. Gastroenterology 86:174–193
Chung KT, Fulk GE, Slein MW (1975) Tryptophanase of fecal flora as a possible factor in the etiology of colon cancer. J Natl Cancer Inst 54:1073–1078
Ganguly NK, Kingham JG, Lloyd B, Lloyd RS, Price CP, Triger DR, Wright R (1978) Acid hydrolases in monocytes from patients with inflammatory bowel disease, chronic liver disease, and rheumatoid arthritis. Lancet 1(8073):1073–1075
Rhodes JM, Gallimore R, Elias E (1985) Fecal mucus degrading glycosidase in ulcerative colitis and Crohn’s disease. Gut 26:761–765
Jung HC, Eckmann I, Yang SK, Panja A, Fierer J, Morzycka-Worblewska E, Kagnoff MF (1995) A distinct array of proinflammatory cytokine is expressed in human colon epithelia cells in response to bacterial invasion. J Clin Invest 95:55–65
Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F (1999) Toll-like receptor-4 mediates lipolysaccharide-induced signal transduction. J Biol Chem 274:10689–10692
Ingalls RR, Heine H, Lien E, Yoshimura A, Glenbock D (1999) Lipopolysaccharide recognition, CD14, and lipopolysaccharide receptors. Infect Dis Clin North Am 13:341–353
Cario E, Pldolsky DK (2000) Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 68:7010–1017
Collins MP, Gibson GR (1999) Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am J Clin Nutr 69:s1052–s1057
Campieri M, Gionchetti P (1999) Probiotics in inflammatory bowel disease: new insight to pathogenesis or a possible therapeutic alternative. Gastroenterology 116:1246–1260
Perdigon G, de Jorrat WEB, de Petrino SF, Valerde de Budeguer M (1991) Effect of oral administration of Lactobacillus casei on various biological functions of the host. Food Agric Immunol 3:93–102
Tabuchi M, Ozaki M, Tamura A, Yamada N, Ishida T, Hosoda M, Hosono A (2003) Antidiabetic effect of Lactobacillus GG in streptozotocin-induced diabetic rats. Biosci Biotechnol Biochem 67:1421–1424
Taranto MP, Medici M, Perdigon G, Ruiz Holgado AP, Valdez GF (1998) Evidence for hypoglycemic effect of Lactobacillus reuteri in hypercholesterolemic mice. J Dairy Sci 81:2336–2340
Daniel C, Poiret S, Goudercourt D, Dennin V, Leyer G, Pot B (2006) Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model. Appl Environ Microbiol 72:5799–5805
Han W, Mercenier A, Ait-Belgnaoui A, Pavan A, Lamine F, van Swam II, Kleerebezem M, Salvador-Cartier C, Hisbergues M, Bueno L, Theodorou V, Fioramonti J (2006) Improvement of an experimental colitis in rats by lactic acid bacteria producing superoxide dismutase. Inflamm Bowel Dis 12:1044–1052
Peran L, Sierra S, Comalada M, Lara-Villoslada F, Bailon E, Nieto A, Olivares M, Zarzuelo A, Xaus J, Galvez J (2007) A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis. Br J Nutr 97:96–103
Chung YW, Choi JH, Oh TY, Eun CS, Han DS (2007) Lactobacillus casei prevents the development of dextran sulfate sodium-induced colitis in toll-like receptor 4 mutant mice. Clin Exp Immunol 151:182–189
Grabig A, Pcclik D, Guzy C, Dankof A, Baumgart DC, Erckenbrecht J, Raupach B, Sonnenborn U, Eckert J, Schumann RR, Wiedenmann B, Dignass AU, Sturm A (2006) Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways. Infect Immun 74:4075–4082
Peran L, Camuesco D, Comalada M, Bailon E, Henriksson A, Xaus J, Zarzuelo A, Galvez J (2007) A comparative study of the preventative effects exerted by three probiotics, Bifidobacterium lactis, Lactobacillus casei and Lactobacillus acidophilus, in the TNBS model of rat colitis. J Appl Microbiol 103:836–844
Han SY, Huh CS, Ahn YT, Lim KS, Baek YJ, Kim DH (2005) Hepatoprotective effect of lactic acid bacteria. J Microbiol Biotechnol 15:887–890
Fukata M, Chen A, Klepper A, Krishnareddy S, Vamadevan AS, Thomas LS, Xu R, Inoue H, Arditi M, Dannenberg AJ, Abreu MT (2006) Cox-2 is regulated by toll-like receptor-4 (TLR4) signaling: role in proliferation and apoptosis in the intestine. Gastroenterology 131:862–877
Hollenbach E, Vieth M, Rosessner A, Neumann M, Malfertheiner P, Naumann M (2005) Inhibition of RICK/Nuclear factor-kB and p38 signalling attenuates the inflammatory response in a murine model of Crohn Disease. J Biol Chem 280:14981–14988
Mullane KM, Kraemer R, Smith B (1985) Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 14:157–167
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Shin YW, Bae EA, Kim SS, Lee YC, Kim DH (2005) Effect of ginsenoside Rb1 and compound K in chronic oxazolone-induced mouse dermatitis. Int Immunopharmacol 5:1183–1191
Duchmann R, Kaiser I, Hermann E, Mayet W, Ewk K, Meyer zum Buschenfelde KH (1995) Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease. Clin Exp Immunol 102:448–455
Kruis W (2004) Antibiotics and probiotics in inflammatory bowel disease. Aliment Pharmacol Ther 20(suppl. 4):75–78
Sartor RB (2004) Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics and prebiotics. Gastroenterology 126:1620–1633
Bowen JM, Stringer AM, Gibson RJ, Yeoh AS, Hannam S, Keefe DM (2007) VSL#3 probiotic treatment reduces chemotherapy-induced diarrhea and weight loss. Cancer Biol Ther 6:1449–1454
Bai A, Lu N, Guo Y, Fan X (2008) Tanshinone IIA ameliorates trinitrobenzene sulfonic acid (TNBS)-induced murine colitis. Dig Dis Sci 53:421–428
Barthet M, Dubucquoy L, Garcia S, Gasmi S, Descreumaux P, Colombel JF, Grimaud JC, Iovanna J, Dagorn JC (2003) Pancreatic changes in TNBS-induced colitis in mice. Gastroenterol Clin Biol 27:895–900
Acknowledgement
This study was supported by a grant from Korea Yakult (2005).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, JH., Lee, B., Lee, HS. et al. Lactobacillus suntoryeus inhibits pro-inflammatory cytokine expression and TLR-4-linked NF-κB activation in experimental colitis. Int J Colorectal Dis 24, 231–237 (2009). https://doi.org/10.1007/s00384-008-0618-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-008-0618-6